Evaluating human cancer cell metastasis in zebrafish

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Teng, Yong ^a   Xie, Xiayang ^a   Walker, Steven ^a   White, David T ^a   Mumm, Jeff S ^a   Cowell, John K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cancer cells; Invasion; Metastasis; Mouse; Zebrafish

Indexed keywords

JANUS KINASE 1; JANUS KINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME LOCALIZATION; EPITHELIUM CELL; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; QUANTITATIVE ANALYSIS; TUMOR INVASION; ZEBRA FISH;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JANUS KINASES; MALE; MICE; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASMS; PHENOTYPE; PROTEIN KINASES; WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY; ZEBRAFISH;

EID: 84884962487     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-453     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. Cancer J Clin 2012, 62:10-29.
2. Yokota J. Tumor progression and metastasis. Carcinogenesis 2000, 21:497-503. 10.1093/carcin/21.3.497, 10688870.
3. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003, 4:51-62. 10.3816/CBC.2003.n.012, 12744759.
4. Sossey-Alaoui K, Li X, Ranalli TA, Cowell JK. WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J Biol Chem 2005, 280:21748-21755. 10.1074/jbc.M500503200, 15826941.
5. Kunapuli P, Chitta KS, Cowell JK. Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene. Oncogene 2003, 22:3985-3991. 10.1038/sj.onc.1206584, 12821932.
6. Goodwin AM. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res 2007, 74:172-183. 10.1016/j.mvr.2007.05.006, 2692317, 17631914.
7. Teng Y, Mei Y, Hawthorn L, Cowell JK. WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene 2013, doi: 10.1038/onc.2012.565. [Epub ahead of print].
8. Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV, Cowell JK. Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 2007, 170:2112-2121. 10.2353/ajpath.2007.060975, 1899429, 17525277.
9. Teng Y, Ren MQ, Cheney R, Sharma S, Cowell JK. Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 2010, 103:1066-1075. 10.1038/sj.bjc.6605850, 2965863, 20717117.
10. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8:353-367. 10.1038/nrg2091, 17440532.
11. Amatruda JF, Shepard JL, Stern HM, Zon LI. Zebrafish as a cancer model system. Cancer Cell 2002, 1:229-231. 10.1016/S1535-6108(02)00052-1, 12086858.
12. Berghmans S, Jette C, Langenau D, Hsu K, Stewart R, Look T, Kanki JP. Making waves in cancer research: new models in the zebrafish. Biotechnology 2005, 39:227-237.
13. Lam SH, Gong Z. Modeling liver cancer using zebrafish: a comparative oncogenomics approach. Cell Cycle 2006, 5:573-577. 10.4161/cc.5.6.2550, 16582610.
14. Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005, 233:1560-1570. 10.1002/dvdy.20471, 15968639.
15. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009, 9:128. 10.1186/1471-2407-9-128, 2697170, 19400945.
16. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J, Hendrix MJ. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 2006, 12:925-932. 10.1038/nm1448, 16892036.
17. Lally BE, Geiger GA, Kridel S, Arcury-Quandt AE, Robbins ME, Kock ND, Wheeler K, Peddi P, Georgakilas A, Kao GD, Koumenis C. Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Res 2007, 67:8791-8799. 10.1158/0008-5472.CAN-07-0477, 3610568, 17875720.
18. Stoletov K, Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008, 27:4509-4520. 10.1038/onc.2008.95, 18372910.
19. Lee SL, Rouhi P, Dahl Jensen L, Zhang D, Ji H, Hauptmann G, Ingham P, Cao Y. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci 2009, 106:19485-19490. 10.1073/pnas.0909228106, 2780785, 19887629.
20. Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, ten Dijke P. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol 2012, 14:717-726. 10.1038/ncb2522, 22706160.
21. Santhakumar K, Judson EC, Elks PM, McKee S, Elworthy S, van Rooijen E, Walmsley SS, Renshaw SA, Cross SS, van Eeden FJ. A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis. Cancer Res 2012, 72:4017-4027. 10.1158/0008-5472.CAN-11-3148, 22665266.
22. Konantz M, Balci TB, Hartwig UF, Dellaire G, André MC, Berman JN, Lengerke C. Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann N Y Acad Sci 2012, 1266:124-137. 10.1111/j.1749-6632.2012.06575.x, 22901264.
23. Sossey-Alaoui K, Su G, Malaj E, Roe B, Cowell JK. WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 2002, 21:5967-5974. 10.1038/sj.onc.1205734, 12185600.
24. Teng Y, Liu M, Cowell JK. Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int J Cancer 2011, 129:2825-2835. 10.1002/ijc.25964, 3154992, 21544801.
25. Teng Y, Ngoka L, Mei Y, Lesoon L, Cowell JK. HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein. J Biol Chem 2012, 287:10051-10059. 10.1074/jbc.M111.335000, 3323057, 22315230.
26. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012, 9:676-682. 10.1038/nmeth.2019, 22743772.
27. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, Wakefield LM. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003, 112:1116-1124. 198530, 14523048.
28. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 1996, 148:313-319. 1861604, 8546221.
29. Staerk J, Kallin A, Demoulin JB, Vainchenker W, Constantinescu SN. JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J Biol Chem 2005, 280:41893-41899. 10.1074/jbc.C500358200, 16239216.
30. Flex E, Petrangeli V, Stella L, Chiaretti S, Hornakova T, Knoops L, Ariola C, Fodale V, Clappier E, Paoloni F, Martinelli S, Fragale A, Sanchez M, Tavolaro S, Messina M, Cazzaniga G, Camera A, Pizzolo G, Tornesello A, Vignetti M, Battistini A, Cavé H, Gelb BD, Renauld JC, Biondi A, Constantinescu SN, Foà R, Tartaglia M. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008, 205:751-758. 10.1084/jem.20072182, 2292215, 18362173.
31. Burfoot MS, Rogers NC, Watling D, Smith JM, Pons S, Paonessaw G, Pellegrini S, White MF, Kerr IM. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem 1997, 272:24183-24190. 10.1074/jbc.272.39.24183, 9305869.
32. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol 1997, 17:695-706. 231795, 9001223.
33. Traver D, Herbomel P, Patton EE, Murphey RD, Yoder JA, Litman GW, Catic A, Amemiya CT, Zon LI, Trede NS. The zebrafish as a model organism to study development of the immune system. Adv Immunol 2003, 81:253-330.
34. Taylor AM, Zon LI. Zebrafish tumor assays: the state of transplantation. Zebrafish 2009, 6:339-346. 10.1089/zeb.2009.0607, 2809423,2809423, 20047467.
35. Liu S, Leach SD. Zebrafish models for cancer. Ann Rev Pathol 2011, 6:671-693.
36. Tran TC, Sneed B, Haider J, Blavo D, White A, Aiyejorun T, Baranowski TC, Rubinstein AL, Doan TN, Dingledine R, Sandberg EM. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res 2007, 7:11386-11392.
37. Rovira M, Huang W, Yusuff S, Shim JS, Ferrante AA, Liu JO, Parsons MJ. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation. Proc Natl Acad Sci 2011, 108:19264-19269. 10.1073/pnas.1113081108, 3228434, 22084084.
38. Etchin J, Kanki JP, Look AT. Zebrafish as a model for the study of human cancer. Methods Cell Biol 2011, 105:309-337.
39. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50:6075-6086.
40. Teng Y, Xie X, Walker S, Rempala G, Kozlowski DJ, Mumm JS, Cowell JK. Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype. Hum Mol Genet 2010, 19:4409-4420. 10.1093/hmg/ddq364, 2957326, 20819949.
41. Teng Y, Xie X, Walker S, Saxena M, Kozlowski DJ, Mumm JS, Cowell JK. Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior. PLoS One 2011, 6:e24596. 10.1371/journal.pone.0024596, 3203530, 22053218.
42. Ariga J, Walker SL, Mumm JS. Multicolor time-lapse imaging of transgenic zebrafish: visualizing retinal stem cells activated by targeted neuronal cell ablation. J Vis Exp 2010, 43:2093. 3157880, 20972390.